'Insulet Corporation (PODD) is Our Top Pick in Diabetes'; PT Raised to $375 at Bernstein
Tweet Send to a Friend
Bernstein SocGen Group analyst Lee Hambright raised the price target on Insulet Corporation (NASDAQ: PODD) to $375.00 (from $355.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
